Hugel Participates in 'IMCAS Asia'... Hosts Exclusive Academic Symposium

Hugel is conducting a solo academic symposium at 'IMCAS Asia 2022' held in Bangkok, Thailand.
[Photo by Hugel]

[Asia Economy Reporter Lee Gwan-joo] Hugel announced on the 6th that it participated in 'IMCAS Asia 2022,' an academic event in the Asia region hosted by the International Master Course on Aging Science (IMCAS), one of the world's top three cosmetic and plastic surgery societies, and held a solo academic symposium.

The conference, held over three days from the 29th of last month to the 1st of this month in Bangkok, Thailand, was attended by about 2,000 medical professionals. Hugel participated in the 'Industrial Session' and held a solo academic symposium on various applications of 'Botulax,' a botulinum toxin product embodying Korea's advanced technology.

At the symposium, in-depth lectures were given on the features and advantages of the botulinum toxin product Botulax, methods of treatment by area, and facial anatomy, which is the basis of the treatment techniques. Unusually for an Industrial Session, about 250 people attended, drawing significant attention.

A Hugel representative said, "This solo symposium served as an opportunity to promote the excellence and safety of Botulax, which holds the number one market share in the local Thai botulinum toxin market and is the first domestic product to enter the Chinese and European markets, to the Asian market and to enhance Hugel's global status. We plan to expand exchanges with medical professionals worldwide through participation in various academic events in the future."

This content was produced with the assistance of AI translation services.